Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma
- PMID: 32978904
- PMCID: PMC7724499
- DOI: 10.1002/cam4.3486
Diagnostic significance and carcinogenic mechanism of pan-cancer gene POU5F1 in liver hepatocellular carcinoma
Abstract
Background: The prognostic and clinicopathological significance of POU Class 5 Homeobox 1 (POU5F1) among various cancers are disputable heretofore. The diagnostic value and functional mechanism of POU5F1 in liver hepatocellular carcinoma (LIHC) have not been studied thoroughly.
Methods: An integrative strategy of meta-analysis, bioinformatics, and wet-lab approach was used to explore the diagnostic and prognostic significance of POU5F1 in various types of tumors, especially in LIHC. Meta-analysis was utilized to investigate the impact of POU5F1 on prognosis and clinicopathological parameters in various cancers. The expression level and diagnostic value of POU5F1 were assessed by qPCR in plasma collected from LIHC patients and controls. The correlation between POU5F1 and tumor infiltrating immune cells (TIICs) in LIHC was evaluated by CIBERSORT. Gene set enrichment analysis (GSEA) was performed based on TCGA. Hub genes and related pathways were identified on the basis of co-expression genes of POU5F1.
Results: Elevated POU5F1 was associated with poor OS, DFS, RFS, and DSS in various cancers. POU5F1 was confirmed as an independent risk factor for LIHC and correlated with tumor occurrence, stage, and invasion depth. The combination of POU5F1 and AFP in plasma was with high diagnostic validity (AUC = 0.902, p < .001). Specifically, the level of POU5F1 was correlated with infiltrating levels of B cells, T cells, dendritic cells, and monocytes in LIHC. GSEA indicated that POU5F1 participated in multiple cancer-related pathways and cell proliferation pathways. Moreover, CBX3, CCHCR1, and NFYC were filtered as the central hub genes of POU5F1.
Conclusion: Our study identified POU5F1 as a pan-cancer gene that could not only be a prognostic and diagnostic biomarker in various cancers, especially in LIHC, but functionally carcinogenic in LIHC.
Keywords: LIHC; POU5F1; biomarker; immune infiltrates; pathogenesis.
© 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures








Similar articles
-
Identification of potential crucial genes associated with the pathogenesis and prognosis of liver hepatocellular carcinoma.J Clin Pathol. 2021 Aug;74(8):504-512. doi: 10.1136/jclinpath-2020-206979. Epub 2020 Oct 1. J Clin Pathol. 2021. PMID: 33004423
-
Identification of Hub Genes in Liver Hepatocellular Carcinoma Based on Weighted Gene Co-expression Network Analysis.Biochem Genet. 2025 Jun;63(3):2120-2139. doi: 10.1007/s10528-024-10803-8. Epub 2024 Apr 29. Biochem Genet. 2025. PMID: 38683466 Free PMC article.
-
Construction of liver hepatocellular carcinoma-specific lncRNA-miRNA-mRNA network based on bioinformatics analysis.PLoS One. 2021 Apr 16;16(4):e0249881. doi: 10.1371/journal.pone.0249881. eCollection 2021. PLoS One. 2021. PMID: 33861762 Free PMC article.
-
Carcinogenesis effects of E2F transcription factor 8 (E2F8) in hepatocellular carcinoma outcomes: an integrated bioinformatic report.Biosci Rep. 2020 Feb 28;40(2):BSR20193212. doi: 10.1042/BSR20193212. Biosci Rep. 2020. PMID: 31990034 Free PMC article.
-
A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.Comput Math Methods Med. 2022 Feb 16;2022:1258480. doi: 10.1155/2022/1258480. eCollection 2022. Comput Math Methods Med. 2022. PMID: 35242200 Free PMC article.
Cited by
-
Aggresome-Autophagy Associated Gene HDAC6 Is a Potential Biomarker in Pan-Cancer, Especially in Colon Adenocarcinoma.Front Oncol. 2021 Aug 17;11:718589. doi: 10.3389/fonc.2021.718589. eCollection 2021. Front Oncol. 2021. PMID: 34485153 Free PMC article.
-
Deep learning-based pathway-centric approach to characterize recurrent hepatocellular carcinoma after liver transplantation.Hum Genomics. 2024 Jun 5;18(1):58. doi: 10.1186/s40246-024-00624-6. Hum Genomics. 2024. PMID: 38840185 Free PMC article.
-
ADGRD1 as a Potential Prognostic and Immunological Biomarker in Non-Small-Cell Lung Cancer.Biomed Res Int. 2022 Nov 22;2022:5699892. doi: 10.1155/2022/5699892. eCollection 2022. Biomed Res Int. 2022. PMID: 36457341 Free PMC article.
-
QPRT Acts as an Independent Prognostic Factor in Invasive Breast Cancer.J Oncol. 2022 Feb 24;2022:6548644. doi: 10.1155/2022/6548644. eCollection 2022. J Oncol. 2022. PMID: 35251175 Free PMC article.
-
Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma.Front Mol Biosci. 2021 May 19;8:670893. doi: 10.3389/fmolb.2021.670893. eCollection 2021. Front Mol Biosci. 2021. PMID: 34095226 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous